New Roche chairman likes things as they are

|About: Roche Holding Ltd (RHHBF)|By:, SA News Editor

New Roche (RHHBF) Chairman Christoph Franz promises continuity after shareholders overwhelmingly approve his appointment.

"This company is on track and therefore continuity is the order of the day," Franz says.

Roche has a number of high-margin new cancer drugs and healthy profits, although it's struggling to reduce its reliance on oncology following setbacks with treatments for diabetes, "good" cholesterol and schizophrenia.

Former CEO and outgoing Chairman Franz Humer says the firm will look at acquisitions, with the company having more strategic flexibility after accumulating cash - it generated 16.4B Swiss francs ($18.6B) in free-cash flow last year.